The Sloan Ventures approach
Built to Win
We invest globally in diagnostic and therapeutic medical devices that can change the course of care in cardiology, neurology, and surgical oncology.
Sloan’s advantage is not just access to information. It is the ability to systematically transform information into better investment decisions—and then help companies execute.
One connected system
Four reinforcing capabilities
0.1
Integrated Expertise
See the whole investment, not isolated pieces.
0.2
Longitudinal Intelligence
Build conviction through time, not a single financing meeting.
0.3
Networked Execution
Turn relationships and specialist capabilities into operating leverage.
0.4
AI-Augmented Judgment
Strengthen and accelerate diligence while partners retain accountability.
From Universe to Conviction
A disciplined path
We do not start with a favorite company and build an investment case around it. We begin with the field, compare opportunities systematically and deliberately surface the strongest candidates.
We review hundreds of companies across defined clinical and technology domains, build structured market maps, track companies longitudinally and compare technologies, teams and trajectories rather than evaluating pitches in isolation.
Map broadly
Compare rigorously
Invest selectively
Distinctive Edge
Compare rigorously
Integrated Expertise
The investment is a system. We evaluate it as one
Clinical need, technology, regulatory pathway, reimbursement, manufacturing, physician adoption, business economics and strategic relevance interact with one another. Sloan brings those perspectives together rather than evaluating them in disciplinary silos.
Individual expertise matters. Integrated judgment matters more.
Longitudinal Intelligence
Companies reveal themselves through time
Tracking companies, technologies and markets longitudinally helps us distinguish persistent advantage from momentary momentum—following changes in strategy, management execution, regulatory progress, clinical evidence, financing history and competitive position.
A single pitch tells us what a company believes today. Longitudinal intelligence helps reveal how it actually executes.
AI-Augmented Judgment
Challenge the thesis—not replace judgment
AI-assisted analysis helps structure evidence, surface inconsistencies, test assumptions and compare opportunities more quickly and consistently. It expands diligence capacity—allowing Sloan to review more opportunities and move through diligence faster without compromising rigor. Investment judgment and accountability remain with Sloan’s partners.
Technology accelerates the work; partners remain accountable for the judgment.
Networked Execution
Turn relationships into operating leverage
We engage systematically and recurrently with clinicians, health systems, medical-device companies, specialist VCs, accelerators, design and development firms, manufacturers and other participants across the medtech ecosystem. These relationships strengthen sourcing, diligence and portfolio execution.
Relationships become an advantage when they are systematic, recurring and integrated into investment and company-building decisions.
Value Creation & Governance
Disciplined investment system
Value Through Dislocation & Execution
Value is not created only at entry
Sloan looks for under-recognized opportunities where specialization reveals value at entry—and integrated expertise helps crystallize that value after investment.
Our involvement does not end when the investment is made. We help portfolio companies navigate the clinical, regulatory, operating and commercial milestones through which value is created.
Strategic Positioning & Exits
Strategic relevance from the outset
We consider the long-term strategic relevance of a technology as part of underwriting—not only when an exit approaches. Understanding where innovation may fit within the evolving medtech landscape helps inform both investment selection and company building.
Rigorous Governance
The foundation beneath the system
Clear authority, accountable decision-making, conflict management, milestone discipline and transparent reporting underpin our investment and ownership approach.
Governance is how conviction become accountable actions – how Sloan Ventures and founders can remain aligned when making difficult choices
The Sloan Ventures Ecosystem
Useful expertise rarely sits in one place
We connect portfolio companies to the capabilities, relationships and market intelligence required at each stage of the medical-device journey.
Partner with Sloan Ventures
Specialist capital—amplified by an operating system
We welcome founders and other others who value systematic research, practical company building and informed partnerships